Murali Srivathsa
Director Ejecutivo en Akura Medical, Inc. .
Perfil
Murali Srivathsa is currently the President & Chief Executive Officer at Akura Medical, Inc. He is also a Director at Zoll Medical Israel Ltd.
Previously, he worked as the Vice President-Sales & Marketing at Medtronic Monitoring, Inc. Mr. Srivathsa holds an MBA from the International Institute for Management Development.
He also completed his undergraduate studies at the University of Bangalore and his graduate studies at The Indian Institute of Foreign Trade.
Cargos activos de Murali Srivathsa
| Empresas | Cargo | Inicio |
|---|---|---|
Zoll Medical Israel Ltd.
 Zoll Medical Israel Ltd. Information Technology ServicesTechnology Services Zoll Medical Israel Ltd. develops patient monitoring solutions for chronic cardiac illnesses. It has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. The firm’s solutions are designed to provide healthcare professionals with accurate and reliable information on the patient's clinical status for support of medical decision-making. The company was founded by y Murali Srivathsa, Uriel Weinstein, Assaf Bernstein, Michal Shohat in 2008 and is headquartered in Kfar Saba, Israel. | Director/Miembro de la Junta | - |
Akura Medical, Inc.
 Akura Medical, Inc. Medical SpecialtiesHealth Technology Akura Medical, Inc. is a privately held medical device company that is developing a next-generation thrombectomy device to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots. Akura Medical is based in Campbell, CA. The company is focused on delivering an effective solution to address the major challenges of venous thromboembolism (VTE). The company was founded in 2019 by Amr Salahieh, Aadel Al-Jadda. Murali Srivathsa has been the CEO of the company since 2022. | Director Ejecutivo | 19/04/2022 |
Antiguos cargos conocidos de Murali Srivathsa.
| Empresas | Cargo | Fin |
|---|---|---|
Medtronic Monitoring, Inc.
 Medtronic Monitoring, Inc. Medical/Nursing ServicesHealth Services Medtronic Monitoring, Inc. treats cardiac arrhythmias. The company was founded in 2005 and is headquartered in San Jose, CA. | Corporate Officer/Principal | - |
Formación de Murali Srivathsa.
| International Institute for Management Development | Masters Business Admin |
| The Indian Institute of Foreign Trade | Graduate Degree |
| University of Bangalore | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Medtronic Monitoring, Inc.
Medtronic Monitoring, Inc. Medical/Nursing ServicesHealth Services Medtronic Monitoring, Inc. treats cardiac arrhythmias. The company was founded in 2005 and is headquartered in San Jose, CA. | Health Services |
Zoll Medical Israel Ltd.
Zoll Medical Israel Ltd. Information Technology ServicesTechnology Services Zoll Medical Israel Ltd. develops patient monitoring solutions for chronic cardiac illnesses. It has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. The firm’s solutions are designed to provide healthcare professionals with accurate and reliable information on the patient's clinical status for support of medical decision-making. The company was founded by y Murali Srivathsa, Uriel Weinstein, Assaf Bernstein, Michal Shohat in 2008 and is headquartered in Kfar Saba, Israel. | Technology Services |
Akura Medical, Inc.
Akura Medical, Inc. Medical SpecialtiesHealth Technology Akura Medical, Inc. is a privately held medical device company that is developing a next-generation thrombectomy device to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots. Akura Medical is based in Campbell, CA. The company is focused on delivering an effective solution to address the major challenges of venous thromboembolism (VTE). The company was founded in 2019 by Amr Salahieh, Aadel Al-Jadda. Murali Srivathsa has been the CEO of the company since 2022. | Health Technology |
- Bolsa de valores
- Insiders
- Murali Srivathsa
